Champions Oncology, Inc.
General ticker "CSBR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $87.8M (TTM average)
Champions Oncology, Inc. does not follow the US Stock Market performance with the rate: -29.5%.
Estimated limits based on current volatility of 1.4%: low 4.73$, high 4.86$
Factors to consider:
- Total employees count: 214 (+0.5%) as of 2026
- Top business risk factors: Inability to raise capital, Sustained profitability failure, Regulatory and compliance, Commercialization failure, Market competition
- Current price 10.9% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-04-30 to 2028-04-29
- 2026-04-30 to 2027-04-30 estimated range: [5.28$, 9.87$]
- 2027-04-30 to 2028-04-29 estimated range: [5.60$, 10.41$]
Financial Metrics affecting the CSBR estimates:
- Positive: with PPE of -297.4 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Positive: -13.52 < Operating profit margin, % of -1.88
- Positive: 12.78 < Shareholder equity ratio, % of 14.59 <= 25.20
- Negative: Inventory ratio change, % of 8.49 > 4.02
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term CSBR quotes
Long-term CSBR plot with estimates
Financial data
| YTD | 2024-04-30 | 2025-04-30 | 2026-04-30 |
|---|---|---|---|
| Operating Revenue | $49.72MM | $56.65MM | $59.42MM |
| Operating Expenses | $57.08MM | $52.10MM | $60.56MM |
| Operating Income | $-7.36MM | $4.55MM | $-1.14MM |
| Non-Operating Income | $0.05MM | $0.07MM | $0.21MM |
| R&D Expense | $9.54MM | $6.83MM | $9.08MM |
| Income(Loss) | $-7.31MM | $4.63MM | $-0.93MM |
| Taxes | $-0.03MM | $-0.07MM | $0.25MM |
| Net Income(Loss)* | $-7.28MM | $4.70MM | $-1.18MM |
| Stockholders Equity | $-1.90MM | $3.77MM | $3.94MM |
| Assets | $26.13MM | $32.34MM | $26.99MM |
| Operating Cash Flow | $-6.14MM | $7.39MM | $-4.47MM |
| Capital expenditure | $0.84MM | $0.39MM | $0.56MM |
| Investing Cash Flow | $-0.84MM | $-0.39MM | $-0.54MM |
| Financing Cash Flow | $-0.53MM | $0.17MM | $0.10MM |
| Earnings Per Share** | $-0.54 | $0.34 | $-0.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.